Staib L - Search Results

1

Is (18)F-fluorodeoxyglucose positron emission tomography in recurrent colorectal cancer a contribution to surgical decision making?

Staib L, Schirrmeister H, Reske SN, Beger HG. Staib L, et al. Am J Surg. 2000 Jul;180(1):1-5. doi: 10.1016/s0002-9610(00)00406-2. Am J Surg. 2000. PMID: 11036130

2

Surgery of colorectal cancer: surgical morbidity and five- and ten-year results in 2400 patients--monoinstitutional experience.

Staib L, Link KH, Blatz A, Beger HG. Staib L, et al. World J Surg. 2002 Jan;26(1):59-66. doi: 10.1007/s00268-001-0182-5. Epub 2001 Nov 26. World J Surg. 2002. PMID: 11898035

3

[PET in pancreatic tumor of unknown origin--luxury or value?].

Staib L, Diederichs C, Reske SN, Beger HG. Staib L, et al. Langenbecks Arch Chir Suppl Kongressbd. 1997;114:471-3. Langenbecks Arch Chir Suppl Kongressbd. 1997. PMID: 9574185 German.

4

FDG PET: elevated plasma glucose reduces both uptake and detection rate of pancreatic malignancies.

Diederichs CG, Staib L, Glatting G, Beger HG, Reske SN. Diederichs CG, et al. Among authors: staib l. J Nucl Med. 1998 Jun;39(6):1030-3. J Nucl Med. 1998. PMID: 9627339 Free article.

5

Detection of liver metastases from pancreatic cancer using FDG PET.

Fröhlich A, Diederichs CG, Staib L, Vogel J, Beger HG, Reske SN. Fröhlich A, et al. Among authors: staib l. J Nucl Med. 1999 Feb;40(2):250-5. J Nucl Med. 1999. PMID: 10025831 Free article.

6

Values and limitations of 18F-fluorodeoxyglucose-positron-emission tomography with preoperative evaluation of patients with pancreatic masses.

Diederichs CG, Staib L, Vogel J, Glasbrenner B, Glatting G, Brambs HJ, Beger HG, Reske SN. Diederichs CG, et al. Among authors: staib l. Pancreas. 2000 Mar;20(2):109-16. doi: 10.1097/00006676-200003000-00001. Pancreas. 2000. PMID: 10707924

7

Follow-up in colorectal cancer: cost-effectiveness analysis of established and novel concepts.

Staib L, Link KH, Beger HG. Staib L, et al. Langenbecks Arch Surg. 2000 Oct;385(6):412-20. doi: 10.1007/s004230000144. Langenbecks Arch Surg. 2000. PMID: 11127527

8

F-18 Fluorodeoxyglucose (FDG) and C-Reactive Protein (CRP).

Diederichs CG, Staib L, Glasbrenner B, Guhlmann A, Glatting G, Pauls S, Beger HG, Reske SN. Diederichs CG, et al. Among authors: staib l. Clin Positron Imaging. 1999 May;2(3):131-136. doi: 10.1016/s1095-0397(99)00019-9. Clin Positron Imaging. 1999. PMID: 14516536

9

Increase of survival benefit in advanced resectable colon cancer by extent of adjuvant treatment: results of a randomized trial comparing modulation of 5-FU + levamisole with folinic acid or with interferon-alpha.

Link KH, Kornmann M, Staib L, Redenbacher M, Kron M, Beger HG; Study Group Oncology of Gastrointestinal Tumors. Link KH, et al. Among authors: staib l. Ann Surg. 2005 Aug;242(2):178-87. doi: 10.1097/01.sla.0000171033.65639.a9. Ann Surg. 2005. PMID: 16041207 Free PMC article. Clinical Trial.

10

Adjuvant treatment of colon and rectal cancer: impact of chemotherapy, radiotherapy, and immunotherapy on routine postsurgical patient management. Forschungsgruppe Onkologie Gastrointestinaler Tumoren (FOGT).

Link KH, Staib L, Kreuser ED, Beger HG. Link KH, et al. Among authors: staib l. Recent Results Cancer Res. 1996;142:311-52. doi: 10.1007/978-3-642-80035-1_19. Recent Results Cancer Res. 1996. PMID: 8893349 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

252 results

Search Page